INTRODUCTION {#s1}
============

Long non coding RNAs (LncRNAs) are a class of regulatory RNAs that are longer than 200 nucleotides and lack protein coding capacity \[[@R1]\]. LncRNAs play critical roles in physiologic and pathologic processes, including carcinogenesis \[[@R2], [@R3]\]. In addition, lncRNAs are also involved in cellular processes such as differentiation \[[@R4]\], proliferation \[[@R5]\], apoptosis \[[@R6]\], metabolism \[[@R7]\] and autophagy \[[@R8]\].

Recently, genome-wide association studies (GWAS) have revealed a large number of genetic variants related to different types of cancer. For examples, Guo et al. identified 45 candidate lncRNAs regulated by noncoding SNPs in prostate cancer \[[@R9]\]. Yuan et al. found that a novel SNP rs114020893 in the lncRNA NEXN-AS1 gene is significantly associated with an increased risk of lung cancer \[[@R10]\]. However, there are some limitations in the GWAS. For examples, at least one-third of the identified variants in non-coding intervals regulatory regions modulate transcription factor binding \[[@R11], [@R12]\], but the relationship between phenotype-related loci and lncRNAs is largely unknown. Furthermore, many GWAS results have shown substantial heterogeneity in allele frequencies across different population \[[@R13]\]. Therefore, further study on a single candidate lncRNA gene in the development of cancer is necessary.

LncRNA HOTAIR, which is located within the Homeobox C (HOXC) gene cluster on chromosome 12 and is co-expressed with HOXC genes, is a inhibitor in the HOXD gene transcription \[[@R14]\]. As an oncogene, HOTAIR is overexpressed in many cancer and involved in cancer proliferation, migration, invasion, progression and poor prognosis, suggesting that it might be a potential novel target in cancer therapy \[[@R15], [@R16]\].

As a class of genetic variants, SNPs are widely used in prediction of disease risk \[[@R17]\], prognosis \[[@R18]\] and clinical outcome \[[@R19]\]. Recently, several studies have summarized the associations of HOTAIR SNPs with cancer risk. However, some results are controversial. For example, two groups reported that there is no association between rs4759314 polymorphism and cancer risk \[[@R20], [@R21]\], but Qi et al. found that rs4759314 is in association with cancer risk \[[@R22]\]. Obviously, the association analysis between HOTAIR SNPs and cancer susceptibility is still necessary.

In the study, a total of 5 SNPs collected from 11 articles were finally enrolled for meta-analysis, three of which were significantly associated with cancer risk, suggesting they are important cancer risk factors and potential targets in future clinical study.

RESULTS {#s2}
=======

Characteristics of eligible studies {#s2_1}
-----------------------------------

A total of 26 articles on relationship between HOTAIR SNPs and cancer risk were retrieved after first search in PubMed, Embase and Web of Science. As shown in Figure [1](#F1){ref-type="fig"}, 11 case-control publications including 10867 patients and 13172 controls met the inclusion criteria and 5 HOTAIR SNPs were involved in the meta-analysis \[[@R23]--[@R33]\]. The main characteristics of 5 HOTAIR SNPs were listed in Table [1](#T1){ref-type="table"}. Of the 11 studies, the HOTAIR rs4759314 in 8 studies \[[@R23]--[@R25], [@R27], [@R29]--[@R32]\], rs920778 in 6 studies \[[@R23], [@R26]--[@R28], [@R30], [@R33]\], rs7958904 in 4 studies \[[@R24], [@R29], [@R31], [@R32]\], rs874945 in 4 studies \[[@R24], [@R29], [@R31], [@R32]\] and rs1899663 in 3 studies \[[@R23], [@R27], [@R30]\] were analyzed, respectively. Genotyping data obtained came from PCR-RFLP and TaqMan detection methods. Genotype and allele frequencies, sample size and other information were revealed in Table [1](#T1){ref-type="table"}. Of the 11 studies, 4 presented a significant deviation from HWE (2 studies on rs4759314 \[[@R31], [@R32]\], 3 on rs920778 \[[@R23], [@R27], [@R33]\] and 2 on rs874945 \[[@R31], [@R32]\]). NOS scale in each study was assessed and the results showed that all the studies had high-quality (Table [2](#T2){ref-type="table"}). Of the 11 studies, 2 populations including Chinese and Turks and 7 types of cancer involving ESCC, colorectal cancer, gastric cancer, breast cancer, osteosarcoma, EOC and cervical cancer were used for group analysis (Table [1](#T1){ref-type="table"}).

![Flow diagram summarizing the selection of eligible studies](oncotarget-08-4460-g001){#F1}

###### Characteristics of studies included in the meta-analysis

  Author           Year   Country   Ethnicity   Cancer Type         Source of Control   Genetyping Method   Case/Control   Case   Control   Risk to cancer   P for HWE   Quality                              
  ---------------- ------ --------- ----------- ------------------- ------------------- ------------------- -------------- ------ --------- ---------------- ----------- --------- ----- ----------- -------- ---
  rs4759314 A\>G   AA     AG        GG          AA                  AG                  GG                                                                                                                    
  Zhang            2014   China     Asian       ESCC                HB                  PCR-PFLP            1000/1000      917    81        2                910         89        1     none        0.436    8
  Xue              2014   China     Asian       Colorectal cancer   HB                  TaqMan              1733/1855      1528   200       5                1608        236       11    none        0.467    7
  Guo              2015   China     Asian       GCA                 HB                  PCR-PFLP            515/654        461    53        1                589         64        1     none        0.587    7
  Pan              2015   China     Asian       Gastric cancer      HB                  PCR-PFLP            500/1000       451    48        1                914         83        3     none        0.448    7
  Du               2015   China     Asian       Gastric cancer      HB                  TaqMan              1275/1644      1083   186       6                1464        172       8     increased   0.230    8
  Yan              2015   China     Asian       Breast cancer       PB                  PCR-PFLP            502/504        451    50        1                448         54        2     none        0.785    7
  Zhou             2016   China     Asian       Osteosarcoma        HB                  TaqMan              500/500        423    62        15               425         64        11    none        \<0.05   7
  Wu               2016   China     Asian       EOC                 HB                  TaqMan              1000/1000      819    140       41               852         125       23    increased   \<0.05   8
  rs920778 C\>T    CC     CT        TT          CC                  CT                  TT                                                                                                                    
  Zhang            2014   China     Asian       ESCC                HB                  PCR-RFLP            2098/2150      1091   826       181              1323        749       78    increased   \<0.05   8
  Bayram           2015   Turkish   Caucasian   Breast cancer       HB                  TaqMan              123/122        31     52        40               15          66        41    increased   0.140    6
  Pan              2015   China     Asian       Gastric cancer      HB                  PCR-RFLP            800/1600       420    321       59               980         575       45    increased   \<0.05   7
  Bayram           2015   Turkish   Caucasian   Gastric cancer      HB                  TaqMan              104/209        20     52        32               38          105       66    none        0.738    6
  Yan              2015   China     Asian       Breast cancer       PB                  PCR-RFLP            502/504        12     151       339              18          190       296   increased   0.060    7
  Qiu              2016   China     Asian       Cervical cancer     HB                  TaqMan              215/430        90     78        47               226         150       54    increased   \<0.05   7
  rs7958904 G\>C   GG     GC        CC          GG                  GC                  CC                                                                                                                    
  Xue              2014   China     Asian       Colorectal cancer   HB                  TaqMan              1731/1852      1019   605       107              992         704       156   decreased   0.052    7
  Du               2015   China     Asian       Gastric cancer      HB                  TaqMan              739/1057       412    276       51               568         404       85    none        0.271    8
  Zhou             2016   China     Asian       Osteosarcoma        HB                  TaqMan              900/900        524    320       56               466         346       88    decreased   \<0.05   7
  Wu               2016   China     Asian       EOC                 HB                  TaqMan              1000/1000      594    355       51               533         380       87    decreased   0.105    8
  rs874945 G\>A    GG     GA        AA          GG                  GA                  AA                                                                                                                    
  Xue              2014   China     Asian       Colorectal cancer   HB                  TaqMan              1147/1202      751    356       40               817         346       39    none        0.749    7
  Du               2015   China     Asian       Gastric cancer      HB                  TaqMan              751/1057       495    225       31               714         307       36    none        0.672    8
  Zhou             2016   China     Asian       Osteosarcoma        HB                  TaqMan              900/900        577    256       67               608         243       49    increased   \<0.05   7
  Wu               2016   China     Asian       EOC                 HB                  TaqMan              1000/1000      665    283       52               677         279       44    none        \<0.05   8
  rs1899663 G\>T   GG     GA        AA          GG                  GA                  AA                                                                                                                    
  Zhang            2014   China     Asian       ESCC                HB                  PCR-RFLP            1000/1000      725    256       19               724         250       26    none        0.430    7
  Pan              2015   China     Asian       Gastric cancer      HB                  PCR-RFLP            500/1000       376    118       6                732         255       13    none        0.078    7
  Yan              2015   China     Asian       Breast cancer       PB                  PCR-RFLP            502/504        339    149       14               326         158       20    none        0.876    7

ESCC: Esophageal squamous cell carcinoma; GCA: Gastric cardia adenocarcinoma; EOC: Epithelial ovarian cancer; HB: Hospital-based; PB: Population-based; HWE: Hardy--Weinberg equilibrium.

###### Newcastle-ottawa quality assessment scale for each included study

  Studies       Selection   Comparability   Exposure   Total quality score                       
  ------------- ----------- --------------- ---------- --------------------- --- --- --- --- --- ---
  Zhang 2014    1           1               1          1                     1   1   0   1   1   8
  Xue 2014      1           1               1          1                     1   1   0   1   0   7
  Guo 2015      1           1               1          1                     1   1   0   1   0   7
  Bayram 2015   1           1               0          1                     1   1   0   1   0   6
  Pan 2015      1           1               1          1                     1   1   0   1   0   7
  Bayram 2015   1           1               0          1                     1   1   0   1   0   6
  Du 2015       1           1               1          1                     1   1   0   1   1   8
  Yan 2015      1           1               1          1                     1   1   0   1   0   7
  Zhou 2016     1           1               1          1                     1   1   0   1   0   7
  Wu 2016       1           1               1          1                     1   1   0   1   1   8
  Qiu 2016      1           1               1          1                     1   1   0   1   0   7

Association between HOTAIR rs4759314 and cancer susceptibility {#s2_2}
--------------------------------------------------------------

We analyzed the association between rs4759314 (A\>G) and cancer susceptibility in 8 studies with 7025 cases and 8157 controls. As a result, we did not find a significant association between rs4759314 (A\>G) and cancer susceptibility in any genetic model in general population. Moreover, we did not find a significant association between them in subgroup analysis of cancer type either (Table [3](#T3){ref-type="table"}).

###### Results of meta-analysis for rs4759314 and rs920778 polymorphisms and the risk of cancer

  Locus              N        OR(95%CI)            P~h~    I^2^(%)    OR(95%CI)            P~h~    I^2^(%)    OR(95%CI)            P~h~    I^2^(%)       OR(95%CI)            P~h~    I^2^(%)       OR(95%CI)            P~h~    I^2^(%)
  ------------------ -------- -------------------- ------- ---------- -------------------- ------- ---------- -------------------- ------- ------------- -------------------- ------- ------------- -------------------- ------- ---------
  rs4759314 A\>G     G VS A                                GG VS AA                                AG VS AA                                AG/GG VS AA                                GG VS AA/AG                                
  Overall            8        1.084(0.933-1.259)   0.018   58.5       1.298(0.916-1.840)   0.483   0.0        1.067(0.922-1.235)   0.065   47.4          1.080(0.929-1.225)   0.036   53.4          1.283(0.906-1.817)   0.504   0.0
  Cancer Types                                                                                                                                                                                                                   
  Digestive cancer   5        1.060(0.861-1.305)   0.018   66.5       0.771(0.403-1.473)   0.778   0.0        1.080(0.866-1.348)   0.017   66.9          1.072(0.860-1.337)   0.015   67.6          0.761(0.398-1.456)   0.789   0.0
  Other cancer       3        1.135(0.904-1.427)   0.160   45.4       1.625(1.064-2.482)   0.506   0.0        1.058(0.876-1.277)   0.555   0.0           1.115(0.915-1.359)   0.300   16.9          1.605(1.051-2.450)   0.531   0.0
  rs920778 C\>T      T VS C                                TT VS CC                                CT VS CC                                CT/TT VS CC                                TT VS CC/CT                                
  Overall            6        1.293(1.105-1.512)   0.002   73.0       1.675(1.034-2.714)   0.000   82.2       1.167(0.946-1.440)   0.029   59.8          1.278(1.025-1.593)   0.010   67.1          1.671(1.195-2.337)   0.000   79.2
  Ethnicity                                                                                                                                                                                                                      
  Asian              4        1.464(1.362-1.574)   0.873   0.0        2.647(2.173-3.226)   0.452   0.0        1.322(1.197-1.459)   0.988   0.0           1.468(1.336-1.613)   0.980   0.0           2.081(1.523-2.845)   0.013   72.3
  Caucasian          2        0.858(0.671-1.096)   0.321   0.0        0.672(0.349-1.293)   0.199   39.4       0.608(0.251-1.474)   0.064   70.8          0.633(0.287-1.397)   0.080   67.4          0.958(0.663-1.383)   0.976   0.0
  Cancer Types                                                                                                                                                                                                                   
  Digestive cancer   3        1.367(1.165-1.605)   0.054   65.8       2.174(1.261-3.748)   0.008   79.4       1.314(1.186-1.455)   0.564   0.0           1.440(1.294-1.601)   0.339   7.6           1.941(1.120-3.364)   0.002   83.7
  Other cancer       3        1.199(0.831-1.731)   0.004   82.4       1.248(0.505-3.084)   0.003   82.9       0.868(0.411-1.834)   0.010   78.2          1.012(0.451-2.271)   0.003   83.2          1.440(1.035-2.002)   0.123   52.3

N: the number of studies; P~h~: P- value for heterogeneity test.

Association between HOTAIR rs920778 and cancer susceptibility {#s2_3}
-------------------------------------------------------------

Association between rs920778 (C\>T ) and cancer risk was analyzed in 6 studies with 3842 cases and 5015 controls. Overall, we observed a significantly increased risk of cancer susceptibility in homozygote comparison, dominant model and recessive model (TT versus CC: OR = 1.675, 95% CI 1.034--2.714, P~h~ \< 0.01; CT/TT versus CC: OR = 1.278, 95% CI 1.025--1.593, P~h~ = 0.10; TT versus CC/CT: OR = 1.671, 95% CI 1.195--2.337, P~h~ \< 0.01), but not in allele contrast model and heterozygote comparison (Table [3](#T3){ref-type="table"}). In subgroup analysis, rs920778 (C\>T ) showed a significant increased risk of cancer in all the genetic models in Asian population (T versus C: OR = 1.464, 95% CI 1.362--1.574, P~h~ = 0.873; TT versus CC: OR = 2.647, 95% CI 2.173--3.226, P~h~ = 0.452; CT versus CC: OR = 1.322, 95% CI 1.197--1.459, P~h~ = 0.988; CT/TT versus CC: OR = 1.468, 95% CI 1.336--1.613, P~h~ = 0.980; TT versus CC/CT: OR = 2.081, 95% CI 1.523--2.845, P~h~ = 0.013) (Figure [2A](#F2){ref-type="fig"}). In cancer type analysis, rs920778 (C\>T) also revealed a significantly increased risk of digestive cancer in all the genetic models (T versus C: OR = 1.367, 95% CI 1.165--1.605, P~h~ = 0.054; TT versus CC: OR = 2.174, 95% CI 1.261--3.748, P~h~ = 0.008; CT versus CC: OR = 1.314, 95% CI 1.186--1.455, P~h~ = 0.564; CT/TT versus CC: OR = 1.440, 95% CI 1.294--1.601, P~h~ = 0.339; TT versus CC/CT: OR = 1.941, 95% CI 1.120--3.364, P~h~ = 0.002) (Figure [2B](#F2){ref-type="fig"}).

![Subgroup analysis on relationship between HOTAIR rs920778 (C\>T ) and cancer risk\
(**A**) Ethnicity analysis. (**B**) Cancer type analysis.](oncotarget-08-4460-g002){#F2}

Association between HOTAIR rs7958904, rs874945 or rs1899663 and cancer susceptibility {#s2_4}
-------------------------------------------------------------------------------------

Analysis results between HOTAIR rs7958904, rs874945 or rs1899663 and cancer risk were shown in Table [4](#T4){ref-type="table"}. In general, there existed a significant association of rs7958904 polymorphism with decreased cancer risk in all genetic models (C versus G: OR = 0.818, 95% CI 0.766--0.875, P~h~ = 0.313; CC versus GG: OR = 0.641, 95% CI 0.544--0.755, P~h~ = 0.319; GC versus GG: OR = 0.853, 95% CI 0.782--0.931, P~h~ = 0.754; GC/CC versus GG: OR = 0.814, 95% CI 0.749--0.884, P~h~ = 0.339; CC versus GG/GC: OR = 0.682, 95% CI 0.582--0.801, P~h~ = 0.393) (Figure [3A](#F3){ref-type="fig"}). When analyzing rs874945, we observed a significantly increased cancer risk in allele contrast model, homozygote comparison and dominant model (A versus G: OR = 1.106, 95% CI 1.021--1.197, P~h~ = 0.816; AA versus GG: OR = 1.259, 95% CI 1.015--1.562, P~h~ = 0.851; GA/AA versus GG: OR = 1.104, 95% CI 1.005--1.212, P~h~ = 0.896), but not in heterozygote comparison and recessive model (Figure [3B](#F3){ref-type="fig"}). Similar to rs4759314, rs1899663 polymorphism was not in significant association with cancer risk in all genetic models (Table [4](#T4){ref-type="table"}).

###### Results of meta-analysis for rs7958904, rs874945 and rs1899663 polymorphisms and the risk of cancer

  Locus            N   OR(95%CI)            P~h~    I^2^ (%)   OR(95%CI)            P~h~    I^2^(%)   OR(95%CI)            P~h~    I^2^(%)   OR(95%CI)            P~h~    I^2^(%)   OR(95%CI)            P~h~    I^2^(%)
  ---------------- --- -------------------- ------- ---------- -------------------- ------- --------- -------------------- ------- --------- -------------------- ------- --------- -------------------- ------- ---------
  rs7958904 G\>C       C VS G                                  CC VS GG                               GC VS GG                               GC/CC VS GG                            CC VS GG/GC                  
  Overall          4   0.818(0.766-0.875)   0.313   15.8       0.641(0.544-0.755)   0.319   14.7      0.853(0.782-0.931)   0.754   0.0       0.814(0.749-0.884)   0.523   0.0       0.682(0.582-0.801)   0.393   0.0
  rs874945 G\>A        A VS G                                  AA VS GG                               GA VS GG                               GA/AA VS GG                            AA VS GG/GA                  
  Overall          4   1.106(1.021-1.197)   0.816   0.0        1.259(1.015-1.562)   0.851   0.0       1.081(0.980-1.193)   0.927   0.0       1.104(1.005-1.212)   0.896   0.0       1.231(0.944-1.523)   0.853   0.0
  rs1899663 G\>T       T VS G                                  TT VS GG                               GT VS GG                               GT/TT VS GG                            TT VS GG/GT                  
  Overall          3   0.928(0.825-1.043)   0.774   0.0        0.737(0.487-1.114)   0.894   0.0       0.956(0.834-1.095)   0.675   0.0       0.937(0.821-1.069)   0.714   0.0       0.746(0.494-1.125)   0.891   0.0

N: the number of studies; P~h~: P- value for heterogeneity test.

![Forest plot of the association between rs7958904 or rs874945 and cancer risk in a homozygote comparison model\
(**A**) rs7958904 analysis result. (**B**) rs874945 analysis result.](oncotarget-08-4460-g003){#F3}

Sensitivity analysis result {#s2_5}
---------------------------

Sensitivity analysis was used to evaluate individual study\'s influence on the pooled results by deleting one single study each time from pooled analysis. As a result, rs920778 in Bayram\'s study \[[@R28]\] had a significant effect on the pooled OR. When this study was excluded in the genotype comparison of TT versus CC, the heterogeneity test was significantly reduced (data not shown).

Publication bias analysis result {#s2_6}
--------------------------------

A funnel plot was generated to assess potential publication bias. As shown in Figure [4](#F4){ref-type="fig"}, there was no any evidence of publication bias in rs4759314, rs7958904 or rs874945 or rs1899663 analysis. Result of publication bias was not shown. There was only slight statistical evidence of publication bias in rs920778 analysis (*P*~b~ = 0.024, *P*~e~ = 0.040).

![Funnel plot for publication bias test\
(**A**) rs4759314 analysis result. (**B**) rs920778 analysis result. (**C**) rs795904 analysis result. (**D**) rs874945 analysis result.](oncotarget-08-4460-g004){#F4}

DISCUSSION {#s3}
==========

In the study, five potential HOTAIR SNPs including rs4759314, rs920778, rs7958904, rs874945 and rs1899663 susceptible to cancer were identified and used for meta-analysis. SNP rs920778, rs4759314 and rs1899663 are located in the introns, rs7958904 in the coding region and rs874945 is close to 3′ region of the HOTAIR gene, respectively \[[@R24]\].

Overall, our results provide evidences that rs920778, rs7958904 and rs874945 but not rs4759314 and rs1899663 loci are related to cancer risk, among of which rs920778 and rs874945 increase and rs7958904 decreases cancer risk, respectively. In the study, we also found that rs920778 is susceptible to cancer in Asian population but not in Turks, which is in accord with Tian\'s study \[[@R20]\]. We speculate that there are two reasons to explain the difference. First, different genetic backgrounds may contribute to divergence because the distribution of HOTAIR allele frequency varies among Asians and Caucasians. Second, different populations have various lifestyles and are influenced by different environmental factors.

Previously, four papers have discussed the association of HOTAIR polymorphisms with cancer risk by meta-analysis \[[@R20]--[@R22], [@R34]\]. In comparison with these studies, our meta-analysis has the following characteristics (Table [5](#T5){ref-type="table"}). In the study, we have selected 11 related articles more than that in any study mentioned above. The enrolled SNPs and cases including patients and controls in our study are also much more than those in any study, implying that our assessment of the relationship between the HOTAIR gene SNPs and cancer risk is relatively more precise. As for rs920778 polymorphism, all five meta-analysis studies including ours have same results which indicate that the polymorphism can increase cancer risk, especially in Asian population and digestive cancer. However, Bayram et al. did not find association of rs920778 to gastric cancer in a Turkish population by a case-control study \[[@R28]\]. For SNP rs4759314, all five meta-analysis studies showed that the SNP is not a risk factor of cancer. For rs1899663, our study together with other three studies also obtained the negative association of the polymorphic site to cancer risk. Same to Zhang\'s group study \[[@R21]\], our group study showed that rs7958904 site decreases cancer risk. In addition, we first analyzed the association of rs874945 to cancer risk. As a result, the polymorphic site decreases the risk of cancer.

###### The characteristics and comparison of different meta-analysis

  Author (Other meta analysis)   Enrolled papers   Case/Control   genetic model                                                                                                         enrolled SNPs   overall risk to cancer   subgroup (ethnicity)   subgroup (cancer type)
  ------------------------------ ----------------- -------------- --------------------------------------------------------------------------------------------------------------------- --------------- ------------------------ ---------------------- ------------------------
  Tian                           8                 7151/8740      three models: heterozygote comparison, homozygote comparison, dominant model                                          rs920778        increased risk           Asian                  digestive cancer
                                                                  One model: dominant model                                                                                             rs4759314       none                     none                   none
                                                                  One model: dominant model                                                                                             rs1899663       none                     none                   none
  Zhang                          6                                five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs920778        increased risk           Asian                  none
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs4759314       none                     none                   none
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs1899663       none                     none                   none
  Qi                             9                 7772/9075      five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs920778        increased risk           Asian                  gastric cancer
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs4759314       none                     none                   none
  Zhang                          8                 7151/8740      four models: allele contrast model, dominant model, recessive model, homozygote comparison                            rs920778        increased risk           Asian                  gastric cancer
                                                                  four models: allele contrast model, dominant model, recessive model, homozygote comparison                            rs4759314       none                     none                   none
                                                                  four models: allele contrast model, dominant model, recessive model, homozygote comparison                            rs1899663       none                     none                   none
                                                                  four models: allele contrast model, dominant model, recessive model, homozygote comparison                            rs7958904       decreased risk           none                   none
  Present study                  11                10867/13172    five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs920778        increased risk           Asian                  digestive cancer
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs4759314       none                     none                   none
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs1899663       none                     none                   none
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs7958904       decreased risk           none                   none
                                                                  five models: allele contrast model, dominant model, recessive model, heterozygote comparison, homozygote comparison   rs874945        increased risk           none                   none

Zhang et al. identified a intronic enhancer between +1719bp and +2353bp from the transcriptional start site of HOTAIR gene and the SNP rs920778 is just located in the region. Moreover, they found that the SNP can increase HOTAIR RNA expression by altering the enhancer activity in esophageal squamous cell carcinoma \[[@R23]\]. As a SNP in the coding sequence, rs7958904 does not alter HOTAIR transcript, but it is predicted to change the secondary structure of HOTAIR, indicating that the SNP deregulates HOTAIR expression by affecting the gene structure, leading to carcinogenesis \[[@R24]\]. SNP rs874945 is near 3′ region of the HOTAIR gene. It is well known that gene 3′ region is a regulatory target of coding gene products \[[@R35]\]and non-coding genes such as microRNA \[[@R36]\]. It has been reported that SNP rs1126579 in the CXCR2 gene 3′ region disrupts the binding site for miR-516a-3p, lead to a moderate increase in CXCR2 mRNA and protein expression, and increased MAPK signaling \[[@R37]\]. Even though SNP rs874945 functional study is not reported, we speculate that it functions by interfering the bind with other coding gene products and non-coding genes.

However, there are several limitations to the present study. Few studies were included in this meta-analysis, and this small sample size limits the power to detect the associations. Because the power of funnel plots, Egger\'s and Begg\'s test of publication bias may also greatly constrain our analysis, our conclusions should be interpreted cautiously. For examples, there was a slight publication bias in the studies on rs920778. We think that only English language studies selected in the study partially contributes the bias. In addition, subgroup analyses of the rs7958904, rs874945 and rs1899663 loci were not performed because the sample size in each study was relatively not large enough.

Although HOTAIR polymorphisms are associated with assessment of cancer risk, abnormal expression of HOTAIR itself is also useful in predicting cancer prognosis. For examples, high HOTAIR level is correlated to poor prognosis in digestive system tumors \[[@R38]\], estrogen-dependent malignant tumors \[[@R39]\], breast cancer, non-small cell lung cancer, laryngeal carcinoma \[[@R40]\], diffuse large B cell lymphoma \[[@R41]\], bladder transitional cell carcinoma \[[@R42]\] and acute leukemia \[[@R43]\]. Thus, HOTAIR is a key LncRNA in genesis and development of cancer.

In conclusion, HOTAIR SNP rs920778, rs7958904 and rs874945 are cancer risk factors, among of which rs920778 is also useful in evaluating cancer risk of Asian population and digestive cancer. Moreover, rs874945 as a cancer risk SNP is first reported in the meta-analysis.

MATERIALS AND METHODS {#s4}
=====================

Identification of eligible studies and data extraction {#s4_1}
------------------------------------------------------

We performed a publication search using PubMed, Embase and Web of Science updated on June 29,2016. The following search terms were used: "HOTAIR OR HOX transcript antisense intergenic RNA","polymorphism OR variation OR variant OR mutation", "cancer OR carcinoma OR tumor OR tumour OR neoplasm", respectively. Searching was done without restriction on language or publication years. Inclusion criteria for studies were as followings: (1) articles on HOTAIR polymorphisms and cancer risk; (2) case-control studies; (3) studies that had detailed genotype frequency of cases and controls or could be calculated from the paper text. Exclusion criteria included: (1) abstract, comment, review; (2) duplication of the previous publications; (3) lack of usable genotype frequency data.

Data extraction {#s4_2}
---------------

Based on the inclusion criteria, two reviewers (ZX Zhang and WN Fu) independently extracted information from all eligible publications. The following information were included in each study: name of first author, year of publication, country, ethnicity, cancer types, source of control, genotyping method, numbers of cases and controls, allele as well as genotype frequencies for cases and controls, *P* value for Hardy--Weinberg equilibrium (HWE), article quality. Different ethnicity descents were categorized as Asians or Caucasians. Study design was stratified into population-based and hospital-based studies. Any disagreement was resolved through discussion until the two reviewers reached a consensus.

Quality score assessment {#s4_3}
------------------------

Two reviewers (ZX Zhang and X Tong) independently assessed the quality of the included studies according to the Newcastle Ottawa Scale (NOS) (<http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>). The scale consists of three components related to sample selection, comparability and ascertainment of exposure.

Statistics analysis {#s4_4}
-------------------

HWE was evaluated using Chi-square test in control groups of each study. Strength of association between HOTAIR SNPs and cancer risk was assessed by odds ratios (ORs) with 95% confidence intervals (CIs). Statistical significance of the pooled OR was determined by Z test. Pooled ORs were used to calculate allele frequency comparison ( rs4759314: G versus A, rs920778: T versus C, rs7958904: C versus G, rs874945: A versus G,rs1899663: T versus G). Five different ORs were calculated according to allele contrast model, dominant model, recessive model, heterozygote comparison and homozygote comparison. Subgroup analyses were performed by cancer types and ethnicities. Heterogeneity degree between different studies was determined by Q-statistic \[[@R44], [@R45]\]. If there was no significance in heterogeneity degree, the fixed effect model (Mantel-Haenszel method) would be used \[[@R46]\]. Otherwise, the random effect model (DerSimonian and Laird method) would be used \[[@R47]\]. Heterogeneity effect was then quantified by I^2^ test. I^2^ statistics represented the proportion of variation across studies due to between-study heterogeneity, and the values of 25%, 50% and 75% were regarded as cut-off points for low, moderate and high degrees of heterogeneity, respectively \[[@R44]\]. Sensitivity analysis was performed to evaluate the stability of the results. Publication bias was evaluated by funnel plot and quantified by Begg\'s test and Egger\'s test to assess funnel plot asymmetry \[[@R48], [@R49]\]. Meta-analyses were performed with the software Stata (Version 12, College Station, Texas, USA). All statistical tests were two-sided and *p* \< 0.05 was considered statistically significant.
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